ReviewBiomedicines2022

Insights into the Role of Gremlin-1, a Bone Morphogenic Protein Antagonist, in Cancer Initiation and Progression.

Noha Mousaad Elemam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.